BBA
AIM

Baader Bank Aktiengesellschaft’s AIM ImmunoTech AIM Stock Holding History

Baader Bank Aktiengesellschaft’s Portfolio AIM Stock Details AIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-134
Closed -$2.37K – 505
2024
Q4 		$2.37K Buy
+134
New +$3.12K ﹤0.01% 378

Other funds holding AIM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Verition Fund Management
Verition Fund Management Greenwich, Connecticut $15.4B AUM 30.69% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Baader Bank Aktiengesellschaft's AIM Position: Q1 2025 in Review

Baader Bank Aktiengesellschaft sold out of AIM ImmunoTech (AIM) in Q1 2025, closing a stake of 134 shares — an estimated $2.37K sold.

Baader Bank Aktiengesellschaft first reported a position in AIM in Q4 2024 and held it in 1 quarter. The position peaked at $2.37K in Q4 2024. 32 funds tracked by Wall St. Rank hold AIM as of Q1 2025.

  • Baader Bank Aktiengesellschaft reported no remaining AIM ImmunoTech position as of Q1 2025 after selling out during the quarter.
  • Baader Bank Aktiengesellschaft sold 134 AIM ImmunoTech shares in Q1 2025, an estimated $2.37K.
  • Baader Bank Aktiengesellschaft first reported a position in AIM ImmunoTech in Q4 2024 and held it in 1 quarter.
  • Baader Bank Aktiengesellschaft's AIM ImmunoTech position peaked at $2.37K in Q4 2024.
  • 32 funds tracked by Wall St. Rank held AIM ImmunoTech as of Q1 2025.

Based on Baader Bank Aktiengesellschaft's 13F filing for Q1 2025, filed 8 May 2025.